Viper ULTRA Tromboliz Kateteri
Bir ultra için özel infüzyon kateteri doğrudan trombolitik dağıtım, aşağıdakileri içerir çoklu delik ilaçları geniş pıhtı segmentlerine eşit olarak dağıtmak için tasarım.
Bu Viper® Ultrasonic Pharmacomechanical Thrombolysis System bir minimal invaziv için tasarlanmış cihaz dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin ve increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications ve preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
Ürün Özellikleri
Şartname | Detay / Değer |
Ürün Adı | Viper ULTRA Tromboliz Kateteri |
Kullanım Amacı | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
Kateter Tasarımı | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
Malzeme | Pebax/Polyamide shaft, potentially braided or reinforced |
Dış Çap (F) | ~4–6F (depending on infusion lumen capacity) |
Çalışma Uzunluğu | ~80–150 cm (varies by product code) |
Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
Kılavuz Tel Uyumluluğu | Typically 0.014” or 0.018” |
Sterilite | Steril, Tek Kullanımlık |
Raf Ömrü | 15-25 °C'de kapalı ambalajda saklandığında ~2-3 yıl |
Klinik Endikasyonlar | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
Kontrendikasyonlar | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
Sipariş ve Boyut Matrisi
Dış Çap (F) | Çalışma Uzunluğu (cm) | Infusion Segment (cm) | Ürün Kodu | Notlar |
4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |